Clinuvel Pharmaceuticals (UR9A.STU) Q3 2026 Earnings

1SepConfirmed
Q1 2026
0.12
0.13
0.15
0.17

Details

Expected EPS
0.31257249779999996
Actual EPS
N/A
Surprise EPS
-0.31
Surprise Percent
+100%

Description

Clinuvel Pharmaceuticals (UR9A.STU) will report earnings of for Q3 2026 on September 01, 2026.

0 Comments

Share your thoughts